OH HB588

Prohibits drug manufacturers, repackagers, third-party logistics providers, and wholesale distributors from denying, restricting, or discriminating against 340B covered entities in acquiring or receiving 340B drugs, unless prohibited by the U.S. Department of Health and Human Services

Prohibits requiring 340B covered entities to submit claims or utilization data as a condition for drug acquisition or delivery, unless required by the U.S. Department of Health and Human Services

Classifies violations as unlawful practices enforceable by the Ohio Attorney General with civil penalties of $50,000 per violation, with each package of 340B drugs subject to a prohibited act constituting a separate violation

Authorizes the Attorney General to refer violations to the Ohio Board of Pharmacy for consideration of sanctions under existing pharmacy regulations

Allows the Attorney General or Board of Pharmacy to adopt rules implementing the section and clarifies the law does not conflict with federal law or other state regulations